Gross-to-Net Optimization Analyzer

Models net realized price for a pharmaceutical product by decomposing gross-to-net across every deduction bucket — rebates, chargebacks, co-pay programs, Medicaid best price exposure, fees, and returns — then quantifies each lever, flags best-price and 340B interactions, and delivers ranked optimization opportunities with a Medicaid best-price impact check. Use when analyzing GTN dynamics, diagnosing net price erosion, evaluating contract or co-pay changes, or building a GTN optimization plan for a branded pharma product.